SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Georgia Bard's Corner -- Ignore unavailable to you. Want to Upgrade?


To: Ga Bard who wrote (4813)11/16/1998 9:53:00 AM
From: jeffrey rainey  Read Replies (1) | Respond to of 9440
 
Business Editors

KETCHUM, Idaho--(BUSINESS WIRE)--Nov. 16, 1998--Thomas Gillespie,
President and Founder of Aqua Vie Beverage Corporation (OTC:AVBCD),
announced today that AVBC had completed the corporate restructuring
program which began in April 1998, and was now completing the 1998
production ramp-up financing, and had also made financing placement
arrangements for a 1999 Worldwide Product Launch of Aqua Vie's 4
existing product lines, as well as its new line of Aqua Vie Smoothies.
Mr. Gillespie stated that, "Although AVBC had expended over
$150,000 to complete the restructuring program, I am satisfied that
the corporate profile is now such that, with the completion of the
$1,000,000 1998 Production Ramp-up Financing this month, as well as
the completion now set for early 1999, of the first of three
$5,000,000 private placement financing arrangements, that there is
sufficient support for the launch of the Domestic and International
Sales and Distribution Program that has been under development
throughout 1998."
Mr. Gillespie stated that, "The restructuring began with a legal
review of AVBC in May of 1998, that was intended to streamline the
AVBC capital structure, provide common stock for the planned 1998 and
1999 financing arrangements, and complete the transactions with
various persons who had supported AVBC prior up through 1998. This was
all accomplished without requiring additional common stock to be
authorized."
"Another objective of the restructuring was to provide an
additional inducement to persons who would provide special services
for AVBCD, during the anticipated growth period of 1999, and beyond.
Through the creation of two new classes of incentive Series A, B
preferred shares, convertible after a three year period to common (to
reduce market-overhang), only 15% of these shares may be sold or
converted by the holders to common during the first 36 months after
issuance and none, can be converted in the first 12 months. An
additional incentive feature of the Series B Shares is an increased
convertibility to common linked to the market price of the common
Shares only if those share increase to more than $5.00/share."
The next objective of the restructuring was to simplify the
accounting for the year-end audit and SEC 1934 Act Form 10 filing and
reporting, planned for early 1999 by the establishment of a Delaware
holding company. On October 15, 1998, Mr. Gillespie said that, "The
company that had been Aqua Vie Beverage Corporation was renamed BEVA
Corporation, and became a wholly owned subsidiary of a holding
company, which assumed the AVBC name and its worldwide operations. As
a result of this transaction, the shareholders became shareholders of
the holding company with exactly the same amount of stock and relative
rights and positions, and with the same management as before, as
required by Delaware law."
"On November 13, 1998, the restructuring program was completed by
the combination of common shares outstanding five to one, and the
combination of Series A, B preferred shares outstanding five to one,
reducing common shares outstanding to approximately 11,000,000 shares,
and leaving almost 40,000,000 common shares in the treasury, all
without the necessity of any additional common stock being authorized.
To effect the combinations, all shareholders will be required to
exchange their certificates for new certificates so that the new CUSIP
number can be imposed."
"In addition to the benefits provided in securing the financing
placement arrangements and SEC compliance, the restructuring enabled
AVBCD to secure the services, in Ketchum, of the Vice President of
Finance, Mr. Cooper, and the Vice President of Administration, Mr.
Wozniak, as announced earlier, as well as support staff domestically
and internationally, and will also assist Aqua Vie in securing future
domestic and foreign location support staff believed necessary to
effect a product launch of the magnitude planned."
"This restructuring was also material in negotiating a definitive
strategic alliance and distribution agreement with Lyons Magnus, which
I consider to be one of the most expansive and lucrative elements in
the 1999 Domestic and International Product Launch."
Mr. Gillespie also said, "Although this announcement was provided
for a general review of the completed restructuring, the details of
the preferred stock, and other transactions are on file in Delaware,
and are available to all shareholders who desire such information."
For further information on Aqua Vie Beverage Corporation, visit
our web site at: aquavie.com.

This release may contain forward-looking statements that involve
risks and uncertainties including, without limitation, continued
acceptance of the company's products and services, increased levels of
competition, new products and technological changes, the company's
dependence upon financing, third-party suppliers and intellectual
property rights, and other risks as may be detailed from time to time
in the company's federal filings, annual report, offering memorandum,
or prospectus.



To: Ga Bard who wrote (4813)11/16/1998 9:58:00 AM
From: Popiye  Read Replies (1) | Respond to of 9440
 
Monday November 16, 8:38 am Eastern Time
Company Press Release
Advanced Optics Electronics Inc. Announces: BioModa Inc. ''Human Clinical Testing Shows Value of New Diagnostic for Early Detection of Lung Cancer''
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Nov. 16, 1998--BioModa Inc. Monday announced the successful completion of the first commercial clinical testing of its TCPP lung cancer diagnostic.

An independent, commercial lung cytology laboratory performed the tests. The blinded study has proven that BioModa's technology is now ready to move into the commercialization phase. The company expects to have its test kit in the marketplace by the end of the first quarter of 1999.

''This is the validation we've been waiting for. Now it's full speed ahead with the kit,'' stated Ari Ma'ayan, BioModa's president. BioModa had hoped that the testing would validate the company's conclusion from earlier laboratory work that the technology would be capable of detecting early stages of pre-cancerous conditions of the lung. ''The trials have done exactly that,'' said BioModa's Chief Technical Officer, Jeff Garwin, M.D., Ph.D.

''The key to raising the survival rate for any type of cancer is early detection, and up until now there was no test which could accurately, quickly and inexpensively detect patterns of abnormal cells in the lung which could develop into lung cancer. This test should detect those patterns several years before any other diagnostic modality,'' stated Dr. Garwin.

Early detection could raise the 5-year survival rate of lung cancer from 15 percent to 46 percent, and new preventive treatments may be able to halt the progression to lung cancer, if pre-cancerous conditions are detected early enough. Lung cancer strikes nearly 200,000 Americans each year and is the leading cause of cancer death in the United States and the world.

BioModa's core technology was developed at Los Alamos National Laboratory and St. Mary's Medical Center in Grand Junction, Colo. BioModa received an exclusive worldwide license to the technology in 1995.

The technology is protected by patents, which have issued in the United States and several foreign countries and which are pending in several more. Additionally, the company will file a number of important new patents in the near future.

BioModa now intends to start developing products to image and treat lung cancer, based on its exclusive core technology. The company also plans to extend its technology to develop diagnostic tests and treatments for other cancers. Plans call for entering into partnerships with U.S.- and foreign-based corporations for R&D, production, marketing and distribution.

Advanced Optics Electronics Inc. currently owns 22.8 percent of BioModa Inc. with an option, if fully exercised which allows Advanced Optics Electronics Inc. position to move to approximately 26.5 percent of BioModa Inc.

Advanced Optics Company Information

Advanced Optics Electronics Inc. (OTC BB:ADOT news) is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM (Spatial Light Modulator) light valve.

This industry-leading technology can be utilized in many diverse fields including the production of ''television quality'' advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission.

Shareholder Relations Note

ADOT will promptly respond to all requests for information from shareholders and the general public; shareholders will receive priority response. All such requests must be sent to ADOT via FAX: 505/858-1871 or U.S. Mail to 8301 Washington Ave. Building 4, Albuquerque, NM 87113. All such requests must include the name, daytime fax (if available) and street address as box numbers cannot be accepted.

This policy is necessitated by the very large number of Internet postings and inquiries, many with pen names which have caused ADOT and other related companies to be overwhelmed with anonymous comments, requests and demands.

This news release contains forward-looking statements with respect to the results of operations and business of the company that involves risk and uncertainties. The company's actual future results could materially differ from those discussed. Risks and uncertainties of the company will be detailed from time to time in the company's periodic reports to be filed with the Securities and Exchange Commission.

Contact Advanced Optics Electronics Inc. at 505/797-7878 or visit their Web site at www.adot.org.



To: Ga Bard who wrote (4813)11/16/1998 10:07:00 AM
From: Ga Bard  Respond to of 9440
 
Highly active .... INFO, NPEC, PNLK, MPTV, KAFE, CRTZ, GOTKQ, ORTG, ADGI,KANA, TSIG

Gary



To: Ga Bard who wrote (4813)11/17/1998 11:31:00 AM
From: CrazyTrain  Read Replies (1) | Respond to of 9440
 
Looking over your list of news releases I see you have listed as a possible daytrade MVEE. I doubt that you will have much luck daytrading it, but if you check into the company and look down the road a little further, you might consider it as a long-term speculative investment. Their first major release "Speedway Junky" was on the "Hot list" (according to the "Hollywood Reporter") at the Milan Film Festival.

"Speedway Junky"
Gus Van Sant
Jesse Bradford
Daryl Hannah
Jonathan Taylor Thomas
Patsy Kensit
Tiffani-Amber Thiessen
Warren G.

Does MVEE look like a penny stock company to you?

I am expecting news of a sale very soon and they have also completed filming of "Delta Force One". G&G are no rookies. They are connected in the film industry. Do your own DD.

Facts Thread:
Subject 22350

Disscusion Thread:
Subject 20125